Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
PACB holding history
Pacific Biosciences of California, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PACB overviewAll 13F holders of PACBFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,766−100.0% | Sold out | Holders |
| Q1 2025 | 10,766 | $12.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,766 | $22.6K | <0.1% | +10,766 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −112,869−100.0% | Sold out | Holders |
| Q1 2024 | 112,869 | $164.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 112,869 | $866.8K | <0.1% | −47,086−29.4% | Reduced | Holders |
| Q3 2023 | 159,955 | $1.28M | <0.1% | +60,365+60.6% | Added | Holders |
| Q2 2023 | 99,590 | $1.28M | <0.1% | +99,226+27,259.9% | Added | Holders |
| Q1 2023 | 364 | $3.99K | <0.1% | −9,035−96.1% | Reduced | Holders |
| Q4 2022 | 9,399 | $92.9K | <0.1% | −8,704−48.1% | Reduced | Holders |
| Q3 2022 | 18,103 | $118.0K | <0.1% | −50.0% | Reduced | Holders |
| Q2 2022 | 18,108 | $84.0K | <0.1% | +17,725+4,627.9% | Added | Holders |
| Q1 2022 | 383 | $3.00K | <0.1% | −113,857−99.7% | Reduced | Holders |
| Q4 2021 | 114,240 | $1.51M | <0.1% | −152,141−57.1% | Reduced | Holders |
| Q3 2021 | 266,381 | $6.81M | <0.1% | −181,712−40.6% | Reduced | Holders |
| Q2 2021 | 448,093 | $15.7M | <0.1% | – | No prior filing | Holders |